home > news > detailed info

ACG to Showcase its Range of Capsules and Engineering Solutions at Supply Side West, Las Vegas

ACG, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical and the nutraceutical industries, will be exhibiting its wide range of Engineering and Capsules solutions at this year’s Supply Side West, Las Vegas. At ACG’s booth, the visitors will be able to see the synergies created with coupling ACG’s Capsules and Engineering products, thereby leveraging the many benefits of integrated manufacturing.

ACG Capsules will be showcasing a wide range of Liquid fill capsules, HPMC capsules, and Clean label products all under ‘ACGCcaps’ name. Apart from being suitable for moisture-sensitive formulation, ACG’s wide range of HPMC capsules also offer superior heat stability with no cross-linking issues with the formulation while meeting standards of Vegetarian society U.K., Certified Vegan, Non-GMO, Star ‘K’ Kosher and Halal. ACG Capsules also offers HPMC solutions including ACGcaps H+, Next-Gen HPMC capsules to enhance product performance and Time-Delayed release HPMC capsules for effective drug delivery.

For nutraceutical companies looking for an exceptional solution for their liquid encapsulation needs, ACG Capsules’ Liquid fill solution will also be displayed at the expo. The liquid encapsulation machine also allows the brands to enhance their identity on the capsule with customized printing, band sealing, and taste and odor masking of formulations.

ACG’s Engineering business will showcase the Fluidocap 1000 - a Semi-automatic Liquid Filling Machine and considered ideal for R&D scale. This compact machine can perform both filling and sealing operations and can handle formulations with a viscosity ranging from 80 cps to 80,000 cps, including pastes, hot melts, and thixotropic formulations. Further, it can be used to fill a large variety of capsules from sizes 00 to 4. Both gelatin and HPMC capsule can be filled using this machine. The machine has an output of 1000 capsules/hour.

Mr. Anil Andrade, Business Head, North America said, “Being the world’s only integrated manufacturing solutions provider for the Pharma and the Nutra industry, ACG firmly believes in partnering with its customers and providing exceptional solutions for their manufacturing needs. Right from the R&D stage to manufacturing product at industrial-scale, customers will find ACG as their committed partner in the entire product manufacturing cycle.”

Using the immersive technology, a unique Virtual Reality dream ride is also arranged at the exhibition which will take the visitors through the world of capsule manufacturing.

Visitors are invited to attend a knowledge session by Mr. Justin Kalafat, Scientific Business Development Manager, ACG North America, on ‘HPMC Capsules: Endless Possibilities for Dietary Supplements’. Mr. Kalafat will discuss the varied applications of HPMC capsules for nutraceutical applications, formulation suitability and the influence of consumer lifestyle preferences.

Come and meet ACG at booth number- 2043.

About ACG

The ACG group is the only supplier in the world offering integrated manufacturing solutions for the pharmaceutical industry. ACG is committed to just one goal: to offer everything needed for efficient capsule and tablet manufacturing. Our customer-centric approach has won us many loyal, satisfied customers and partners by nurturing relationships with dignity and transparency.

For media inquiries, please contact Corporate Communications team at:

+91 8879793484 / +91 9871830883
Print this page
Send to a friend
News and Press Releases

Signant Health Appoints Lawrence Miller as Chief Technology Officer

LONDON & PHILADELPHIA – June 13, 2019: Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer. Signant unites electronic Clinical Outcomes Assessment (eCOA), eConsent, Patient Engagement, Interactive Response Technology (IRT), Clinical Supply Management and Endpoint Quality into the industry’s most comprehensive patient-centric suite of technology solutions and services. An accomplished innovator, Miller brings unique vision and expertise to a Signant team already committed to advancing clinical research with its next-generation technology portfolio.
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals – gaining strong, new industry contacts and building on existing ones.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement